nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—NISCH—Podofilox—Teniposide—lymphatic system cancer	0.0264	0.709	CbGdCrCtD
Guanabenz—NISCH—Vinblastine—Vincristine—lymphatic system cancer	0.0108	0.29	CbGdCrCtD
Guanabenz—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00254	0.00263	CcSEcCtD
Guanabenz—Haemoglobin—Carmustine—lymphatic system cancer	0.00252	0.00262	CcSEcCtD
Guanabenz—Urticaria—Teniposide—lymphatic system cancer	0.00252	0.00261	CcSEcCtD
Guanabenz—Oliguria—Methotrexate—lymphatic system cancer	0.00251	0.00261	CcSEcCtD
Guanabenz—Haemorrhage—Carmustine—lymphatic system cancer	0.00251	0.0026	CcSEcCtD
Guanabenz—Abdominal pain—Teniposide—lymphatic system cancer	0.0025	0.0026	CcSEcCtD
Guanabenz—Body temperature increased—Teniposide—lymphatic system cancer	0.0025	0.0026	CcSEcCtD
Guanabenz—Erythema—Bleomycin—lymphatic system cancer	0.0025	0.0026	CcSEcCtD
Guanabenz—Paraesthesia—Fludarabine—lymphatic system cancer	0.0025	0.0026	CcSEcCtD
Guanabenz—Dyspnoea—Fludarabine—lymphatic system cancer	0.00248	0.00258	CcSEcCtD
Guanabenz—Oedema peripheral—Carmustine—lymphatic system cancer	0.00247	0.00257	CcSEcCtD
Guanabenz—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00246	0.00256	CcSEcCtD
Guanabenz—Dyspepsia—Fludarabine—lymphatic system cancer	0.00245	0.00254	CcSEcCtD
Guanabenz—Decreased appetite—Fludarabine—lymphatic system cancer	0.00242	0.00251	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.0024	0.0025	CcSEcCtD
Guanabenz—Fatigue—Fludarabine—lymphatic system cancer	0.0024	0.00249	CcSEcCtD
Guanabenz—Inflammation—Methotrexate—lymphatic system cancer	0.00238	0.00248	CcSEcCtD
Guanabenz—Constipation—Fludarabine—lymphatic system cancer	0.00238	0.00247	CcSEcCtD
Guanabenz—Pain—Fludarabine—lymphatic system cancer	0.00238	0.00247	CcSEcCtD
Guanabenz—Vasculitis—Methotrexate—lymphatic system cancer	0.00237	0.00246	CcSEcCtD
Guanabenz—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00235	0.00244	CcSEcCtD
Guanabenz—Eye disorder—Carmustine—lymphatic system cancer	0.00234	0.00243	CcSEcCtD
Guanabenz—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00234	0.00243	CcSEcCtD
Guanabenz—Hypersensitivity—Teniposide—lymphatic system cancer	0.00233	0.00242	CcSEcCtD
Guanabenz—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00233	0.00242	CcSEcCtD
Guanabenz—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00232	0.00241	CcSEcCtD
Guanabenz—Anaemia—Bleomycin—lymphatic system cancer	0.00231	0.0024	CcSEcCtD
Guanabenz—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00229	0.00238	CcSEcCtD
Guanabenz—Asthenia—Teniposide—lymphatic system cancer	0.00227	0.00236	CcSEcCtD
Guanabenz—Malaise—Bleomycin—lymphatic system cancer	0.00225	0.00234	CcSEcCtD
Guanabenz—Pruritus—Teniposide—lymphatic system cancer	0.00224	0.00233	CcSEcCtD
Guanabenz—Leukopenia—Bleomycin—lymphatic system cancer	0.00224	0.00232	CcSEcCtD
Guanabenz—Skin exfoliation—Methotrexate—lymphatic system cancer	0.00221	0.00229	CcSEcCtD
Guanabenz—Body temperature increased—Fludarabine—lymphatic system cancer	0.0022	0.00229	CcSEcCtD
Guanabenz—Erythema—Carmustine—lymphatic system cancer	0.00218	0.00227	CcSEcCtD
Guanabenz—Malnutrition—Carmustine—lymphatic system cancer	0.00218	0.00227	CcSEcCtD
Guanabenz—Cough—Bleomycin—lymphatic system cancer	0.00218	0.00227	CcSEcCtD
Guanabenz—Diarrhoea—Teniposide—lymphatic system cancer	0.00217	0.00225	CcSEcCtD
Guanabenz—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00216	0.00224	CcSEcCtD
Guanabenz—Chest pain—Bleomycin—lymphatic system cancer	0.00213	0.00221	CcSEcCtD
Guanabenz—Myalgia—Bleomycin—lymphatic system cancer	0.00213	0.00221	CcSEcCtD
Guanabenz—Back pain—Carmustine—lymphatic system cancer	0.00211	0.00219	CcSEcCtD
Guanabenz—Discomfort—Bleomycin—lymphatic system cancer	0.0021	0.00218	CcSEcCtD
Guanabenz—Chills—Mitoxantrone—lymphatic system cancer	0.00209	0.00217	CcSEcCtD
Guanabenz—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.00206	0.00214	CcSEcCtD
Guanabenz—Confusional state—Bleomycin—lymphatic system cancer	0.00206	0.00214	CcSEcCtD
Guanabenz—Vision blurred—Carmustine—lymphatic system cancer	0.00206	0.00214	CcSEcCtD
Guanabenz—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00205	0.00213	CcSEcCtD
Guanabenz—Oedema—Bleomycin—lymphatic system cancer	0.00204	0.00212	CcSEcCtD
Guanabenz—Erythema—Mitoxantrone—lymphatic system cancer	0.00203	0.00211	CcSEcCtD
Guanabenz—Infection—Bleomycin—lymphatic system cancer	0.00203	0.00211	CcSEcCtD
Guanabenz—Anaemia—Carmustine—lymphatic system cancer	0.00202	0.0021	CcSEcCtD
Guanabenz—Back pain—Vincristine—lymphatic system cancer	0.00202	0.00209	CcSEcCtD
Guanabenz—Vomiting—Teniposide—lymphatic system cancer	0.00201	0.00209	CcSEcCtD
Guanabenz—Agitation—Carmustine—lymphatic system cancer	0.00201	0.00208	CcSEcCtD
Guanabenz—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.002	0.00208	CcSEcCtD
Guanabenz—Asthenia—Fludarabine—lymphatic system cancer	0.002	0.00207	CcSEcCtD
Guanabenz—Rash—Teniposide—lymphatic system cancer	0.002	0.00207	CcSEcCtD
Guanabenz—Dermatitis—Teniposide—lymphatic system cancer	0.00199	0.00207	CcSEcCtD
Guanabenz—Headache—Teniposide—lymphatic system cancer	0.00198	0.00206	CcSEcCtD
Guanabenz—Pruritus—Fludarabine—lymphatic system cancer	0.00197	0.00205	CcSEcCtD
Guanabenz—Back pain—Mitoxantrone—lymphatic system cancer	0.00196	0.00204	CcSEcCtD
Guanabenz—Leukopenia—Carmustine—lymphatic system cancer	0.00195	0.00203	CcSEcCtD
Guanabenz—Anorexia—Bleomycin—lymphatic system cancer	0.00195	0.00202	CcSEcCtD
Guanabenz—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00193	0.002	CcSEcCtD
Guanabenz—Anaemia—Vincristine—lymphatic system cancer	0.00193	0.002	CcSEcCtD
Guanabenz—Agitation—Vincristine—lymphatic system cancer	0.00191	0.00199	CcSEcCtD
Guanabenz—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00191	0.00199	CcSEcCtD
Guanabenz—Hypotension—Bleomycin—lymphatic system cancer	0.00191	0.00198	CcSEcCtD
Guanabenz—Diarrhoea—Fludarabine—lymphatic system cancer	0.0019	0.00198	CcSEcCtD
Guanabenz—Hypertension—Carmustine—lymphatic system cancer	0.00188	0.00196	CcSEcCtD
Guanabenz—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00188	0.00196	CcSEcCtD
Guanabenz—Nausea—Teniposide—lymphatic system cancer	0.00188	0.00195	CcSEcCtD
Guanabenz—Anaemia—Mitoxantrone—lymphatic system cancer	0.00188	0.00195	CcSEcCtD
Guanabenz—Leukopenia—Vincristine—lymphatic system cancer	0.00187	0.00194	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00186	0.00193	CcSEcCtD
Guanabenz—Chest pain—Carmustine—lymphatic system cancer	0.00186	0.00193	CcSEcCtD
Guanabenz—Myalgia—Carmustine—lymphatic system cancer	0.00186	0.00193	CcSEcCtD
Guanabenz—Anxiety—Carmustine—lymphatic system cancer	0.00185	0.00192	CcSEcCtD
Guanabenz—Paraesthesia—Bleomycin—lymphatic system cancer	0.00183	0.0019	CcSEcCtD
Guanabenz—Malaise—Mitoxantrone—lymphatic system cancer	0.00183	0.0019	CcSEcCtD
Guanabenz—Dyspnoea—Bleomycin—lymphatic system cancer	0.00182	0.00189	CcSEcCtD
Guanabenz—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00182	0.00189	CcSEcCtD
Guanabenz—Hypertension—Vincristine—lymphatic system cancer	0.0018	0.00187	CcSEcCtD
Guanabenz—Confusional state—Carmustine—lymphatic system cancer	0.0018	0.00187	CcSEcCtD
Guanabenz—Oedema—Carmustine—lymphatic system cancer	0.00178	0.00185	CcSEcCtD
Guanabenz—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00178	0.00185	CcSEcCtD
Guanabenz—Decreased appetite—Bleomycin—lymphatic system cancer	0.00177	0.00184	CcSEcCtD
Guanabenz—Myalgia—Vincristine—lymphatic system cancer	0.00177	0.00184	CcSEcCtD
Guanabenz—Cough—Mitoxantrone—lymphatic system cancer	0.00177	0.00184	CcSEcCtD
Guanabenz—Infection—Carmustine—lymphatic system cancer	0.00177	0.00184	CcSEcCtD
Guanabenz—Vomiting—Fludarabine—lymphatic system cancer	0.00177	0.00184	CcSEcCtD
Guanabenz—Rash—Fludarabine—lymphatic system cancer	0.00175	0.00182	CcSEcCtD
Guanabenz—Dermatitis—Fludarabine—lymphatic system cancer	0.00175	0.00182	CcSEcCtD
Guanabenz—Hypertension—Mitoxantrone—lymphatic system cancer	0.00175	0.00182	CcSEcCtD
Guanabenz—Pain—Bleomycin—lymphatic system cancer	0.00175	0.00181	CcSEcCtD
Guanabenz—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00174	0.00181	CcSEcCtD
Guanabenz—Headache—Fludarabine—lymphatic system cancer	0.00174	0.00181	CcSEcCtD
Guanabenz—Tachycardia—Carmustine—lymphatic system cancer	0.00174	0.00181	CcSEcCtD
Guanabenz—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00173	0.00179	CcSEcCtD
Guanabenz—Chest pain—Mitoxantrone—lymphatic system cancer	0.00173	0.00179	CcSEcCtD
Guanabenz—Myalgia—Mitoxantrone—lymphatic system cancer	0.00173	0.00179	CcSEcCtD
Guanabenz—Anxiety—Mitoxantrone—lymphatic system cancer	0.00172	0.00179	CcSEcCtD
Guanabenz—Discomfort—Mitoxantrone—lymphatic system cancer	0.00171	0.00177	CcSEcCtD
Guanabenz—Oedema—Vincristine—lymphatic system cancer	0.0017	0.00177	CcSEcCtD
Guanabenz—Anorexia—Carmustine—lymphatic system cancer	0.0017	0.00176	CcSEcCtD
Guanabenz—Infection—Vincristine—lymphatic system cancer	0.00169	0.00175	CcSEcCtD
Guanabenz—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00168	0.00175	CcSEcCtD
Guanabenz—Confusional state—Mitoxantrone—lymphatic system cancer	0.00167	0.00173	CcSEcCtD
Guanabenz—Nervous system disorder—Vincristine—lymphatic system cancer	0.00167	0.00173	CcSEcCtD
Guanabenz—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00166	0.00173	CcSEcCtD
Guanabenz—Hypotension—Carmustine—lymphatic system cancer	0.00166	0.00173	CcSEcCtD
Guanabenz—Oedema—Mitoxantrone—lymphatic system cancer	0.00166	0.00172	CcSEcCtD
Guanabenz—Nausea—Fludarabine—lymphatic system cancer	0.00165	0.00172	CcSEcCtD
Guanabenz—Infection—Mitoxantrone—lymphatic system cancer	0.00165	0.00171	CcSEcCtD
Guanabenz—Shock—Mitoxantrone—lymphatic system cancer	0.00163	0.00169	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00162	0.00169	CcSEcCtD
Guanabenz—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00162	0.00168	CcSEcCtD
Guanabenz—Urticaria—Bleomycin—lymphatic system cancer	0.00162	0.00168	CcSEcCtD
Guanabenz—Anorexia—Vincristine—lymphatic system cancer	0.00162	0.00168	CcSEcCtD
Guanabenz—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00162	0.00168	CcSEcCtD
Guanabenz—Body temperature increased—Bleomycin—lymphatic system cancer	0.00161	0.00168	CcSEcCtD
Guanabenz—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00161	0.00167	CcSEcCtD
Guanabenz—Paraesthesia—Carmustine—lymphatic system cancer	0.0016	0.00166	CcSEcCtD
Guanabenz—Hypotension—Vincristine—lymphatic system cancer	0.00159	0.00165	CcSEcCtD
Guanabenz—Dyspnoea—Carmustine—lymphatic system cancer	0.00159	0.00165	CcSEcCtD
Guanabenz—Anorexia—Mitoxantrone—lymphatic system cancer	0.00158	0.00164	CcSEcCtD
Guanabenz—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00155	0.00161	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00155	0.00161	CcSEcCtD
Guanabenz—Decreased appetite—Carmustine—lymphatic system cancer	0.00155	0.00161	CcSEcCtD
Guanabenz—Hypotension—Mitoxantrone—lymphatic system cancer	0.00155	0.00161	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00154	0.0016	CcSEcCtD
Guanabenz—Paraesthesia—Vincristine—lymphatic system cancer	0.00153	0.00159	CcSEcCtD
Guanabenz—Constipation—Carmustine—lymphatic system cancer	0.00152	0.00158	CcSEcCtD
Guanabenz—Pain—Carmustine—lymphatic system cancer	0.00152	0.00158	CcSEcCtD
Guanabenz—Breast disorder—Methotrexate—lymphatic system cancer	0.00152	0.00158	CcSEcCtD
Guanabenz—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00151	0.00157	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00151	0.00157	CcSEcCtD
Guanabenz—Hypersensitivity—Bleomycin—lymphatic system cancer	0.0015	0.00156	CcSEcCtD
Guanabenz—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00149	0.00154	CcSEcCtD
Guanabenz—Decreased appetite—Vincristine—lymphatic system cancer	0.00148	0.00154	CcSEcCtD
Guanabenz—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00148	0.00153	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00147	0.00152	CcSEcCtD
Guanabenz—Feeling abnormal—Carmustine—lymphatic system cancer	0.00147	0.00152	CcSEcCtD
Guanabenz—Fatigue—Vincristine—lymphatic system cancer	0.00147	0.00152	CcSEcCtD
Guanabenz—Asthenia—Bleomycin—lymphatic system cancer	0.00146	0.00152	CcSEcCtD
Guanabenz—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00146	0.00151	CcSEcCtD
Guanabenz—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00146	0.00151	CcSEcCtD
Guanabenz—Constipation—Vincristine—lymphatic system cancer	0.00145	0.00151	CcSEcCtD
Guanabenz—Pain—Vincristine—lymphatic system cancer	0.00145	0.00151	CcSEcCtD
Guanabenz—Pruritus—Bleomycin—lymphatic system cancer	0.00144	0.0015	CcSEcCtD
Guanabenz—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00144	0.0015	CcSEcCtD
Guanabenz—Fatigue—Mitoxantrone—lymphatic system cancer	0.00143	0.00148	CcSEcCtD
Guanabenz—Pain—Mitoxantrone—lymphatic system cancer	0.00142	0.00147	CcSEcCtD
Guanabenz—Constipation—Mitoxantrone—lymphatic system cancer	0.00142	0.00147	CcSEcCtD
Guanabenz—Abdominal pain—Carmustine—lymphatic system cancer	0.00141	0.00146	CcSEcCtD
Guanabenz—Body temperature increased—Carmustine—lymphatic system cancer	0.00141	0.00146	CcSEcCtD
Guanabenz—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00139	0.00144	CcSEcCtD
Guanabenz—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00139	0.00144	CcSEcCtD
Guanabenz—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00136	0.00142	CcSEcCtD
Guanabenz—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00135	0.00141	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00135	0.0014	CcSEcCtD
Guanabenz—Abdominal pain—Vincristine—lymphatic system cancer	0.00134	0.0014	CcSEcCtD
Guanabenz—Body temperature increased—Vincristine—lymphatic system cancer	0.00134	0.0014	CcSEcCtD
Guanabenz—Urticaria—Mitoxantrone—lymphatic system cancer	0.00132	0.00137	CcSEcCtD
Guanabenz—Hypersensitivity—Carmustine—lymphatic system cancer	0.00131	0.00136	CcSEcCtD
Guanabenz—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00131	0.00136	CcSEcCtD
Guanabenz—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00131	0.00136	CcSEcCtD
Guanabenz—Vomiting—Bleomycin—lymphatic system cancer	0.0013	0.00135	CcSEcCtD
Guanabenz—Infestation NOS—Methotrexate—lymphatic system cancer	0.00129	0.00134	CcSEcCtD
Guanabenz—Infestation—Methotrexate—lymphatic system cancer	0.00129	0.00134	CcSEcCtD
Guanabenz—Rash—Bleomycin—lymphatic system cancer	0.00129	0.00134	CcSEcCtD
Guanabenz—Dermatitis—Bleomycin—lymphatic system cancer	0.00129	0.00134	CcSEcCtD
Guanabenz—Asthenia—Carmustine—lymphatic system cancer	0.00128	0.00133	CcSEcCtD
Guanabenz—Hypersensitivity—Vincristine—lymphatic system cancer	0.00125	0.0013	CcSEcCtD
Guanabenz—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00122	0.00127	CcSEcCtD
Guanabenz—Asthenia—Vincristine—lymphatic system cancer	0.00122	0.00127	CcSEcCtD
Guanabenz—Diarrhoea—Carmustine—lymphatic system cancer	0.00122	0.00127	CcSEcCtD
Guanabenz—Nausea—Bleomycin—lymphatic system cancer	0.00121	0.00126	CcSEcCtD
Guanabenz—Asthenia—Mitoxantrone—lymphatic system cancer	0.00119	0.00123	CcSEcCtD
Guanabenz—Dizziness—Carmustine—lymphatic system cancer	0.00118	0.00122	CcSEcCtD
Guanabenz—Haemoglobin—Methotrexate—lymphatic system cancer	0.00117	0.00121	CcSEcCtD
Guanabenz—Diarrhoea—Vincristine—lymphatic system cancer	0.00116	0.00121	CcSEcCtD
Guanabenz—Haemorrhage—Methotrexate—lymphatic system cancer	0.00116	0.00121	CcSEcCtD
Guanabenz—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00113	0.00118	CcSEcCtD
Guanabenz—Vomiting—Carmustine—lymphatic system cancer	0.00113	0.00118	CcSEcCtD
Guanabenz—Dizziness—Vincristine—lymphatic system cancer	0.00112	0.00117	CcSEcCtD
Guanabenz—Rash—Carmustine—lymphatic system cancer	0.00112	0.00117	CcSEcCtD
Guanabenz—Dermatitis—Carmustine—lymphatic system cancer	0.00112	0.00117	CcSEcCtD
Guanabenz—Headache—Carmustine—lymphatic system cancer	0.00112	0.00116	CcSEcCtD
Guanabenz—Erythema multiforme—Methotrexate—lymphatic system cancer	0.0011	0.00114	CcSEcCtD
Guanabenz—Eye disorder—Methotrexate—lymphatic system cancer	0.00109	0.00113	CcSEcCtD
Guanabenz—Tinnitus—Methotrexate—lymphatic system cancer	0.00108	0.00112	CcSEcCtD
Guanabenz—Vomiting—Vincristine—lymphatic system cancer	0.00108	0.00112	CcSEcCtD
Guanabenz—Rash—Vincristine—lymphatic system cancer	0.00107	0.00111	CcSEcCtD
Guanabenz—Dermatitis—Vincristine—lymphatic system cancer	0.00107	0.00111	CcSEcCtD
Guanabenz—Headache—Vincristine—lymphatic system cancer	0.00107	0.00111	CcSEcCtD
Guanabenz—Nausea—Carmustine—lymphatic system cancer	0.00106	0.0011	CcSEcCtD
Guanabenz—Vomiting—Mitoxantrone—lymphatic system cancer	0.00105	0.00109	CcSEcCtD
Guanabenz—Immune system disorder—Methotrexate—lymphatic system cancer	0.00105	0.00109	CcSEcCtD
Guanabenz—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00105	0.00109	CcSEcCtD
Guanabenz—Rash—Mitoxantrone—lymphatic system cancer	0.00104	0.00108	CcSEcCtD
Guanabenz—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00104	0.00108	CcSEcCtD
Guanabenz—Chills—Methotrexate—lymphatic system cancer	0.00104	0.00108	CcSEcCtD
Guanabenz—Headache—Mitoxantrone—lymphatic system cancer	0.00104	0.00108	CcSEcCtD
Guanabenz—Erythema—Methotrexate—lymphatic system cancer	0.00101	0.00105	CcSEcCtD
Guanabenz—Malnutrition—Methotrexate—lymphatic system cancer	0.00101	0.00105	CcSEcCtD
Guanabenz—Nausea—Vincristine—lymphatic system cancer	0.00101	0.00105	CcSEcCtD
Guanabenz—Nausea—Mitoxantrone—lymphatic system cancer	0.000984	0.00102	CcSEcCtD
Guanabenz—Back pain—Methotrexate—lymphatic system cancer	0.000978	0.00102	CcSEcCtD
Guanabenz—Vision blurred—Methotrexate—lymphatic system cancer	0.000953	0.00099	CcSEcCtD
Guanabenz—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000938	0.000974	CcSEcCtD
Guanabenz—Anaemia—Methotrexate—lymphatic system cancer	0.000934	0.000971	CcSEcCtD
Guanabenz—Malaise—Methotrexate—lymphatic system cancer	0.000912	0.000947	CcSEcCtD
Guanabenz—Leukopenia—Methotrexate—lymphatic system cancer	0.000905	0.00094	CcSEcCtD
Guanabenz—Cough—Methotrexate—lymphatic system cancer	0.000882	0.000916	CcSEcCtD
Guanabenz—Chest pain—Methotrexate—lymphatic system cancer	0.000861	0.000894	CcSEcCtD
Guanabenz—Myalgia—Methotrexate—lymphatic system cancer	0.000861	0.000894	CcSEcCtD
Guanabenz—Arthralgia—Methotrexate—lymphatic system cancer	0.000861	0.000894	CcSEcCtD
Guanabenz—Discomfort—Methotrexate—lymphatic system cancer	0.00085	0.000883	CcSEcCtD
Guanabenz—Confusional state—Methotrexate—lymphatic system cancer	0.000832	0.000864	CcSEcCtD
Guanabenz—Infection—Methotrexate—lymphatic system cancer	0.00082	0.000851	CcSEcCtD
Guanabenz—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000809	0.00084	CcSEcCtD
Guanabenz—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000808	0.000839	CcSEcCtD
Guanabenz—Skin disorder—Methotrexate—lymphatic system cancer	0.000801	0.000832	CcSEcCtD
Guanabenz—Anorexia—Methotrexate—lymphatic system cancer	0.000786	0.000817	CcSEcCtD
Guanabenz—Hypotension—Methotrexate—lymphatic system cancer	0.000771	0.000801	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000752	0.000781	CcSEcCtD
Guanabenz—Paraesthesia—Methotrexate—lymphatic system cancer	0.000741	0.00077	CcSEcCtD
Guanabenz—Dyspnoea—Methotrexate—lymphatic system cancer	0.000736	0.000764	CcSEcCtD
Guanabenz—Dyspepsia—Methotrexate—lymphatic system cancer	0.000726	0.000754	CcSEcCtD
Guanabenz—Decreased appetite—Methotrexate—lymphatic system cancer	0.000717	0.000745	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000712	0.00074	CcSEcCtD
Guanabenz—Fatigue—Methotrexate—lymphatic system cancer	0.000711	0.000739	CcSEcCtD
Guanabenz—Pain—Methotrexate—lymphatic system cancer	0.000706	0.000733	CcSEcCtD
Guanabenz—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00068	0.000706	CcSEcCtD
Guanabenz—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000675	0.000701	CcSEcCtD
Guanabenz—Urticaria—Methotrexate—lymphatic system cancer	0.000655	0.000681	CcSEcCtD
Guanabenz—Body temperature increased—Methotrexate—lymphatic system cancer	0.000652	0.000677	CcSEcCtD
Guanabenz—Abdominal pain—Methotrexate—lymphatic system cancer	0.000652	0.000677	CcSEcCtD
Guanabenz—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000608	0.000631	CcSEcCtD
Guanabenz—Asthenia—Methotrexate—lymphatic system cancer	0.000592	0.000615	CcSEcCtD
Guanabenz—Pruritus—Methotrexate—lymphatic system cancer	0.000584	0.000606	CcSEcCtD
Guanabenz—Diarrhoea—Methotrexate—lymphatic system cancer	0.000565	0.000586	CcSEcCtD
Guanabenz—Dizziness—Methotrexate—lymphatic system cancer	0.000546	0.000567	CcSEcCtD
Guanabenz—Vomiting—Methotrexate—lymphatic system cancer	0.000525	0.000545	CcSEcCtD
Guanabenz—Rash—Methotrexate—lymphatic system cancer	0.00052	0.00054	CcSEcCtD
Guanabenz—Dermatitis—Methotrexate—lymphatic system cancer	0.00052	0.00054	CcSEcCtD
Guanabenz—Headache—Methotrexate—lymphatic system cancer	0.000517	0.000537	CcSEcCtD
Guanabenz—Nausea—Methotrexate—lymphatic system cancer	0.00049	0.000509	CcSEcCtD
